Researchers at Kanazawa University report in Cell Stem Cell how the Spred1 molecule is involved in hematopoietic stem cell self-renewal. Experiments with mouse models show that under normal conditions, Spred1 acts as a...
Researchers at Kanazawa University report in Cell Stem Cell how the Spred1 molecule is involved in hematopoietic stem cell self-renewal. Experiments with mouse models show that under normal conditions, Spred1 acts as a...
CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its first quarter 2018 financial results on Thursday, May 3, 2018, after the close of the U.S. financial markets. Following...
CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its first quarter 2018 financial results on Thursday, May 3, 2018, after the close of the U.S. financial markets. Following...
Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the...
Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the...
QUEBEC CITY and MYRTLE BEACH, SC, April 26, 2018 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the...
QUEBEC CITY and MYRTLE BEACH, SC, April 26, 2018 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the...
The sleep apnea devices market is projected to grow at a CAGR of 7.8%. The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018. The major influencing factors...
The sleep apnea devices market is projected to grow at a CAGR of 7.8%. The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018. The major influencing factors...
This Persistence Market Research report examines the global western blotting market for the period 2017–2025.Western blotting technique or protein immunoblot is used for detection and quantification of specific protein...
This Persistence Market Research report examines the global western blotting market for the period 2017–2025.Western blotting technique or protein immunoblot is used for detection and quantification of specific protein...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 26, 2018 /PRNewswire/ -- The "Medical Device Contract Manufacturing Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 26, 2018 /PRNewswire/ -- The "Medical Device Contract Manufacturing Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report...
Hospital and health system partnership transactions are continuing at a brisk pace in 2018. Thirty transactions were announced in the first quarter, up more than 11 percent from the first quarter of 2017, according to the...
Hospital and health system partnership transactions are continuing at a brisk pace in 2018. Thirty transactions were announced in the first quarter, up more than 11 percent from the first quarter of 2017, according to the...
The "Bio-Pharmaceutical Logistics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering. The report predicts the global...
The "Bio-Pharmaceutical Logistics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering. The report predicts the global...
One is an MIT professor who has been called the "Indiana Jones of Astronomy" because of her quest to find the "Holy Grail of Planetary Science"-a second Earth. Another is a Russian-Canadian programmer, age 24, who created...
One is an MIT professor who has been called the "Indiana Jones of Astronomy" because of her quest to find the "Holy Grail of Planetary Science"-a second Earth. Another is a Russian-Canadian programmer, age 24, who created...
In the iconic Hall of Knights, packed with public and policymakers, Dutch biotech Micreos 'sustainable alternative to antibiotics' was chosen as Europe's most relevant innovation, at the finals of the...
In the iconic Hall of Knights, packed with public and policymakers, Dutch biotech Micreos 'sustainable alternative to antibiotics' was chosen as Europe's most relevant innovation, at the finals of the...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 26, 2018 /PRNewswire/ -- The "Patient Scales - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The rep...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 26, 2018 /PRNewswire/ -- The "Patient Scales - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The rep...
The occlusion devices market projected to grow at a CAGR of 5.3%. The global occlusion devices market is projected to reach USD 3.55 billion by 2023 from USD 2.74 billion in 2018, at a CAGR of 5.3%. Growth in target...
The occlusion devices market projected to grow at a CAGR of 5.3%. The global occlusion devices market is projected to reach USD 3.55 billion by 2023 from USD 2.74 billion in 2018, at a CAGR of 5.3%. Growth in target...
Lipotriad Vitamins LLC is pleased to announce that it has signed an exclusive distribution agreement in Puerto Rico with Advanced Ophthalmic Solutions Corp.
Lipotriad Vitamins LLC is pleased to announce that it has signed an exclusive distribution agreement in Puerto Rico with Advanced Ophthalmic Solutions Corp.
The global magnetic resonance imaging (MRI) systems market is projected to grow at a CAGR of 3.9%. Download the full report: https://www.reportbuyer.com/product/4397153 The MRI systems market is expected to reach USD...
The global magnetic resonance imaging (MRI) systems market is projected to grow at a CAGR of 3.9%. Download the full report: https://www.reportbuyer.com/product/4397153 The MRI systems market is expected to reach USD...
The global HPAPIs market projected to grow at a CAGR of 8.7% The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by...
The global HPAPIs market projected to grow at a CAGR of 8.7% The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by...
ReportsnReports.com adds 2015-2023 World Platelet Rich Plasma Market (PRP) Research Report by Product Type, End-User (Application) and Regions (Countries) in its Pharmaceuticals research library. Platelet Rich Plasma...
ReportsnReports.com adds 2015-2023 World Platelet Rich Plasma Market (PRP) Research Report by Product Type, End-User (Application) and Regions (Countries) in its Pharmaceuticals research library. Platelet Rich Plasma...
InTouch Health, the leading enterprise virtual care platform, today announces McLaren Health Care, a Michigan-based integrated health network, has expanded its telehealth offerings to implement InTouch Health's new...
InTouch Health, the leading enterprise virtual care platform, today announces McLaren Health Care, a Michigan-based integrated health network, has expanded its telehealth offerings to implement InTouch Health's new...
Rapid + TCT 2018 – Manufacturers using additive manufacturing (AM) processes can now easily use the high-resolution imaging and elemental analysis capabilities of scanning electron microscopy (SEM) to characterize powders...
Rapid + TCT 2018 – Manufacturers using additive manufacturing (AM) processes can now easily use the high-resolution imaging and elemental analysis capabilities of scanning electron microscopy (SEM) to characterize powders...
For the third consecutive year, Astellas makes the Best Workplace in Canada list, ranking 21st, along with Best in Large and Multinational Workplace, and a Best Workplace for Women in Canada
For the third consecutive year, Astellas makes the Best Workplace in Canada list, ranking 21st, along with Best in Large and Multinational Workplace, and a Best Workplace for Women in Canada
Marketnewsupdates.com News Commentary When people order a hamburger at a restaurant it's almost impossible to know whether that burger will cause nausea, vomiting, or even diarrhea later on that night. In fact, most...
Marketnewsupdates.com News Commentary When people order a hamburger at a restaurant it's almost impossible to know whether that burger will cause nausea, vomiting, or even diarrhea later on that night. In fact, most...
QUEBEC CITY and MYRTLE BEACH, SC, April 26, 2018 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that an...
QUEBEC CITY and MYRTLE BEACH, SC, April 26, 2018 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that an...
Vyaire Medical (the "Company"), a global leader in respiratory care, today announced that it has acquired Acutronic Medical Systems and, separately, entered into a definitive agreement to acquire imtmedical.
Vyaire Medical (the "Company"), a global leader in respiratory care, today announced that it has acquired Acutronic Medical Systems and, separately, entered into a definitive agreement to acquire imtmedical.
Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2018.
Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2018.
The global cell culture market was valued at US$13,000.0 mn in 2016, and is further expected to register a revenue worth around US$29,000.0 mn by 2025. Such a growth in terms of revenue gained is expected to occur...
The global cell culture market was valued at US$13,000.0 mn in 2016, and is further expected to register a revenue worth around US$29,000.0 mn by 2025. Such a growth in terms of revenue gained is expected to occur...
Mazor Robotics Ltd. (TASE: MZOR) (NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic guidance systems, announced today that it will report financial results for the first quarter ended March 31, 2018,...
Mazor Robotics Ltd. (TASE: MZOR) (NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic guidance systems, announced today that it will report financial results for the first quarter ended March 31, 2018,...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD),...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD),...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Asembia, the leading provider of collaborative solutions and group purchasing services to the specialty pharmacy industry, is pleased to announce the opening of an additional office space in Trevose, PA. With four...
Asembia, the leading provider of collaborative solutions and group purchasing services to the specialty pharmacy industry, is pleased to announce the opening of an additional office space in Trevose, PA. With four...
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and...
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and...
Datum Dental, Ltd, leading provider of OSSIX® brand innovative solutions for bone and tissue regeneration for dentistry, announces expansion of its global distribution network. In the USA, Dentsply Sirona Implants is now...
Datum Dental, Ltd, leading provider of OSSIX® brand innovative solutions for bone and tissue regeneration for dentistry, announces expansion of its global distribution network. In the USA, Dentsply Sirona Implants is now...
In an exclusive report, Transparency Market Research has compiled a range of sections analyzing the expansion of the global EP catheter ablation market for the assessment period, 2017-2026. The study delivers insightful...
In an exclusive report, Transparency Market Research has compiled a range of sections analyzing the expansion of the global EP catheter ablation market for the assessment period, 2017-2026. The study delivers insightful...
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today is informing stockholders that GtreeBNT,...
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today is informing stockholders that GtreeBNT,...
DURECT Corporation (Nasdaq: DRRX) today announced it has commenced patient dosing in a Phase 2a clinical trial of DUR-928 in patients with alcoholic hepatitis (AH). DUR-928, the lead investigational product in our...
DURECT Corporation (Nasdaq: DRRX) today announced it has commenced patient dosing in a Phase 2a clinical trial of DUR-928 in patients with alcoholic hepatitis (AH). DUR-928, the lead investigational product in our...
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AMRN, APRI, DEPO, and DRRX which can be accessed for free by signing up to...
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AMRN, APRI, DEPO, and DRRX which can be accessed for free by signing up to...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of preliminary data from Part 1, the dose finding portion, of the ongoing FIREFISH clinical trial. The open-label trial is evaluating RG7916, an oral...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of preliminary data from Part 1, the dose finding portion, of the ongoing FIREFISH clinical trial. The open-label trial is evaluating RG7916, an oral...
Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2018. Key results include:
Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2018. Key results include:
Brooks Automation, Inc. (Nasdaq: BRKS) announced today that it has acquired BioSpeciMan Corporation, a Canadian provider of storage services for biological sample materials headquartered in Montreal, Canada with operations...
Brooks Automation, Inc. (Nasdaq: BRKS) announced today that it has acquired BioSpeciMan Corporation, a Canadian provider of storage services for biological sample materials headquartered in Montreal, Canada with operations...
About Student Microscope A student microscope is defined as an optical microscope that is used in primary, secondary and tertiary educational institutions. Read the full report: https://www.reportlinker.com/p03588365 ...
About Student Microscope A student microscope is defined as an optical microscope that is used in primary, secondary and tertiary educational institutions. Read the full report: https://www.reportlinker.com/p03588365 ...
Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor Stephen Scherer,...
Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor Stephen Scherer,...
Global Child Resistant Closures Market: Overview This Transparency Market Research report examines the global child resistant closures market for the forecast period 2017–2025. The primary objective of the report is to...
Global Child Resistant Closures Market: Overview This Transparency Market Research report examines the global child resistant closures market for the forecast period 2017–2025. The primary objective of the report is to...
Global Phytonutrients Market: Overview This report analyzes and forecasts the market for phytonutrients at the global and regional level.The market has been forecast based on revenue (US$ Mn) and Volume (Tons) from 2017 to...
Global Phytonutrients Market: Overview This report analyzes and forecasts the market for phytonutrients at the global and regional level.The market has been forecast based on revenue (US$ Mn) and Volume (Tons) from 2017 to...
More than 4,000 managed care pharmacy professionals and stakeholders from across the country have gathered in Boston this week to attend the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy...
More than 4,000 managed care pharmacy professionals and stakeholders from across the country have gathered in Boston this week to attend the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy...
Amicrobe, Inc. uses advanced bioengineering principles to develop novel antimicrobial products for the era of antibiotic resistance. Today, the company announced that it has filed an international PCT patent application...
Amicrobe, Inc. uses advanced bioengineering principles to develop novel antimicrobial products for the era of antibiotic resistance. Today, the company announced that it has filed an international PCT patent application...
Scientific research is repeatedly demonstrating that metal exposure can be a contributing factor to autoimmune disease, warns the International Academy of Oral Medicine and Toxicology (IAOMT).
Scientific research is repeatedly demonstrating that metal exposure can be a contributing factor to autoimmune disease, warns the International Academy of Oral Medicine and Toxicology (IAOMT).
The "Global Prosthetic Robot Arm Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global prosthetic robot arm market to grow at a CAGR of 11.28% during the period 2018-2022. Global...
The "Global Prosthetic Robot Arm Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global prosthetic robot arm market to grow at a CAGR of 11.28% during the period 2018-2022. Global...
Urovant Sciences, a global biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced that it has strengthened its management team through the appointment of five senior...
Urovant Sciences, a global biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced that it has strengthened its management team through the appointment of five senior...
Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces that data collected from two Phase 1 studies of its proprietary Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for Parkinson's disease were...
Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces that data collected from two Phase 1 studies of its proprietary Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for Parkinson's disease were...
Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate CBP-201, the company's monoclonal antibody candidate for allergic...
Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate CBP-201, the company's monoclonal antibody candidate for allergic...
VANCOUVER, April 23, 2018 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter ended March 31, 2018, on Monday, April 30, 2018 after market close.
VANCOUVER, April 23, 2018 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter ended March 31, 2018, on Monday, April 30, 2018 after market close.
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on received a notification letter from...
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on received a notification letter from...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Medical Device Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com'...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Medical Device Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com'...
Today, Kroger (NYSE: KR) and Cardinal Health (NYSE: CAH) announced the companies will host joint drug take-back events at more than 100 Kroger Family of Pharmacies locations from 10 a.m. – 2 p.m. local time on April 28,...
Today, Kroger (NYSE: KR) and Cardinal Health (NYSE: CAH) announced the companies will host joint drug take-back events at more than 100 Kroger Family of Pharmacies locations from 10 a.m. – 2 p.m. local time on April 28,...
Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to...
Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to...
This report analyzes the worldwide markets for Patient Scales in US$ Thousand by the following Product Segments: Floor Scales, Infant & Baby Scales, Chair Scales, and Under Bed Scales. Download the full report:...
This report analyzes the worldwide markets for Patient Scales in US$ Thousand by the following Product Segments: Floor Scales, Infant & Baby Scales, Chair Scales, and Under Bed Scales. Download the full report:...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Surgical Drapes and Gowns Market by Type (Drapes, Gown), Utility (Reusable, Disposable), End User (Hospital) - Global Foreca...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Surgical Drapes and Gowns Market by Type (Drapes, Gown), Utility (Reusable, Disposable), End User (Hospital) - Global Foreca...
Demonstrating its advanced manufacturing technologies and an innovative approach to custom manufacturing, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., will attend NPE 2018: The Plastics...
Demonstrating its advanced manufacturing technologies and an innovative approach to custom manufacturing, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., will attend NPE 2018: The Plastics...
Allergy relief brand to help allergy sufferers share how they really feel
Allergy relief brand to help allergy sufferers share how they really feel
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at the 28th European Congress of...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at the 28th European Congress of...
Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership of Grünenthal's research and development...
Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership of Grünenthal's research and development...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone, with 90% occurring in Africa. Toshihiro Mita from the Juntendo University...
Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone, with 90% occurring in Africa. Toshihiro Mita from the Juntendo University...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the results of key secondary outcome measures from Phase 3 clinical trials (BHV3000-301 and BHV3000-302) of rimegepant, the first oral CGRP receptor...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the results of key secondary outcome measures from Phase 3 clinical trials (BHV3000-301 and BHV3000-302) of rimegepant, the first oral CGRP receptor...
Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including...
Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including...
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual...
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual...
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018.
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018.
Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in...
Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in...
Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, will deliver a mini-oral presentation and two additional posters at the European Congress...
Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, will deliver a mini-oral presentation and two additional posters at the European Congress...
Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the American Academy of Neurology (AAN) which will focus on neuromuscular medical...
Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the American Academy of Neurology (AAN) which will focus on neuromuscular medical...
Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company's supplemental New Drug Application (sNDA) which seeks a new indication for...
Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company's supplemental New Drug Application (sNDA) which seeks a new indication for...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Bruker Corporation 60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Ad...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Bruker Corporation 60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Ad...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 20, 2018 /PRNewswire/ -- The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offe...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 20, 2018 /PRNewswire/ -- The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offe...
High-accuracy multi-wavelength digital refractometer with the V-block method, optimal for measurements of optical materials Shimadzu Corporation has released the KPR-300 Kalnew precision refractometer in North America....
High-accuracy multi-wavelength digital refractometer with the V-block method, optimal for measurements of optical materials Shimadzu Corporation has released the KPR-300 Kalnew precision refractometer in North America....
Heidelberg University Hospital in Germany has entered into a partnership with RaySearch Laboratories AB (publ) to pioneer the RayCare™ oncology information system. The research partnership, which focuses on supporting...
Heidelberg University Hospital in Germany has entered into a partnership with RaySearch Laboratories AB (publ) to pioneer the RayCare™ oncology information system. The research partnership, which focuses on supporting...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
The "Pharma E-commerce Market in Europe 2018-2022" report has been added to ResearchAndMarkets.com's offering. The pharma e-commerce market in Europe to grow at a CAGR of 13.82% during the period 2018-2022. Pharma...
The "Pharma E-commerce Market in Europe 2018-2022" report has been added to ResearchAndMarkets.com's offering. The pharma e-commerce market in Europe to grow at a CAGR of 13.82% during the period 2018-2022. Pharma...
Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published results from a Phase 3, randomized, head-to-head efficacy study that found an...
Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published results from a Phase 3, randomized, head-to-head efficacy study that found an...
This report analyzes the worldwide markets for Operating Tables in US$ Thousand by the following Product Segments: General Operating Tables, and Specialty Operating Tables. Download the full report:...
This report analyzes the worldwide markets for Operating Tables in US$ Thousand by the following Product Segments: General Operating Tables, and Specialty Operating Tables. Download the full report:...
This report analyzes the worldwide markets for Intravenous Equipment in US$ Thousand by the following Segments: Intravenous Catheters, and Intravenous Infusion Pumps and Sets. Download the full report:...
This report analyzes the worldwide markets for Intravenous Equipment in US$ Thousand by the following Segments: Intravenous Catheters, and Intravenous Infusion Pumps and Sets. Download the full report:...
The global optical microscopes market was valued at around US$ 1.5 Bn in 2016 and is anticipated to expand at a CAGR of around 6% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR)...
The global optical microscopes market was valued at around US$ 1.5 Bn in 2016 and is anticipated to expand at a CAGR of around 6% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR)...
Eisai Inc. will present six posters on FYCOMPA® (perampanel) CIII at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles from April 21-27. The poster presentations will include analyses on long-term...
Eisai Inc. will present six posters on FYCOMPA® (perampanel) CIII at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles from April 21-27. The poster presentations will include analyses on long-term...
Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today Sanofi purchased the Beacon platform to accelerate their cell line...
Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today Sanofi purchased the Beacon platform to accelerate their cell line...
Global sales and marketing firm ZS is excited to announce a new partnership with Valkre Solutions, an account-based sales and marketing cloud software provider. ZS will leverage Valkre's software to transform the...
Global sales and marketing firm ZS is excited to announce a new partnership with Valkre Solutions, an account-based sales and marketing cloud software provider. ZS will leverage Valkre's software to transform the...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey....
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey....
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have...
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have...
BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector. The majority of...
BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector. The majority of...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive...
Global Circular Dichroism (CD) Spectrometers Market: Overview Circular dichroism (CD) spectrometer is an analytical instrument used to analyze the molecular structure and chiral activity of organic molecules.It is widely...
Global Circular Dichroism (CD) Spectrometers Market: Overview Circular dichroism (CD) spectrometer is an analytical instrument used to analyze the molecular structure and chiral activity of organic molecules.It is widely...
Once-daily Xultophy® has been shown to help patients achieve blood glucose targets
Once-daily Xultophy® has been shown to help patients achieve blood glucose targets
Softheon, a national leader in cloud-based health insurance exchange integration and services, announced today its private-label enrollment solution, which provides Enhanced Direct Enrollment-as-a-service (EDE); a unified...
Softheon, a national leader in cloud-based health insurance exchange integration and services, announced today its private-label enrollment solution, which provides Enhanced Direct Enrollment-as-a-service (EDE); a unified...
Howard University Hospital's (HUH) Department of Trauma and Critical Care recently teamed up with staff members at H.D. Woodson Senior High School in Washington, D.C., to conduct a "Stop the Bleed" Training.
Howard University Hospital's (HUH) Department of Trauma and Critical Care recently teamed up with staff members at H.D. Woodson Senior High School in Washington, D.C., to conduct a "Stop the Bleed" Training.
According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Material Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use...
According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Material Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 18, 2018 /PRNewswire/ -- The "Endoscopy Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. Gastrointest...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 18, 2018 /PRNewswire/ -- The "Endoscopy Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. Gastrointest...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Xencor to perform...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Xencor to perform...
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease...
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical...
Navigator Business Solutions, an SAP implementation Gold Partner, has just released a pair of turnkey ERP solutions tailored specifically for medical device and pharmaceutical manufacturers.
Navigator Business Solutions, an SAP implementation Gold Partner, has just released a pair of turnkey ERP solutions tailored specifically for medical device and pharmaceutical manufacturers.
